Delivery Order SPE2DR25D2108-SPE2DR26F6SQ9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Arimidex 1 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $9,475.20, is scheduled for completion by January 12, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, demonstrating the contractor's capability to meet federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 count) under a firm fixed-price contract valued at $12,043.27. This non-competitive award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $19,490.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Arimidex 1 mg tablets (30-count units). This is a non-set-aside contract with a completion date of January 21, 2026, with performance fulfillment at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $73,658.77 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded delivery order was issued on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $5,852.78 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The company will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $12,855.70 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages). This competitive, non-set-aside award is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,515.83 to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 30, 2026, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc....
- The Defense Logistics Agency awarded a delivery order valued at $12,971.08 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a 30-count package. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,731.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6SQ9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,862.78 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a quantity of 30 units. This competitive, firm fixed-price delivery order was issued on January 29, 2026, with an ultimate completion date of January 30, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under a larger Indefinite Delivery Contract vehicle held by the parent company, Cencora, Inc., which does business as AmerisourceBergen. This delivery order is executed under Cencora, Inc.'s comprehensive $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen functions as a critical pharmaceutical distributor within the federal supply chain, providing brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Arimidex order fulfills ongoing pharmaceutical requirements for military medical facilities and represents a routine transactional award under this established indefinite delivery contract vehicle with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 1/28/26 |